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Abstract
Toxoplasma gondii is one of the opportunistic pathogen that causes toxoplasmosis. Infection of Toxoplasma 
gondii has been estimated as high both in human and animal. The manifestation of infection were abortion, 
hydrocephalus, brain calcification, chorioretinal scar, and loss of productivity even to death in patients with 
acquired immunosuppression. Early diagnostic method which are  rapid and accurate is essential for T. 
gondii detection because of its high prevalence. The purpose of this study was to develop a sensitive probes 
derived from Surface Antigen 1 (SAG1) for detection T. gondii and to examine the specificity and sensitivity of 
probe as diagnostic tool for toxoplasmosis. This research used SAG1 gene of T. gondii local isolate IS-1 that 
was cloned into pGEX-2T and transformed into Eschericia coli DH5α. The sequence of SAG1 was labeled with 
DIGoxigenin (non radioactive labeled) using PCR DIG Labeling Mix to derive 213 bp (probe-TS). BLAST and 
dot-blot hybridization analyses showed that probes had high specifity with other strains of T. gondii. Probe 
was able to detect T. gondii DNAup to 10 ng/μl of total sample DNA. 
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Introduction
Toxoplasmosis is a zoonotic disease 
caused by obligate intracellular parasite 
Toxoplasma gondii, which infects all warm-
blooded animals including humans (Carruthers 
and Boothroyd, 2007; Craeye et al., 2008; Ma et 
al., 2009; Sibley et al., 2009). It is estimated that 
Toxoplasmosis infects 30% to 50% of the entire 
human population in the world (Aspinall et al, 
2002; Weiss and Dubey, 2009). In Indonesia , the 
prevalence of toxoplasmosis in humans ranges 
from 2% -63% (Gandahusada, 1998). 
In a person with a good immune 
system, infections caused by T. gondii does 
not cause serious problems even no symptoms 
(asymptomatic) but can be fatal if the infection 
is congenital and occur to patients with 
immunosuppression (Chintana et al, 1998), 
as well as to patients whose immune systems 
are interrupted such as encephalitis, AIDS, 
transplantation, chemotherapy , and ocular 
lesions (Yamamoto et al., 2000; Sibley et al., 
2009). In animals, infection of T. gondii could 
reduce the productivity of livestock and be a 
source of transmission of infection to humans 
(Dubey, 2008). 
Humans could be infected with T. gondii 
through variety ways, such as (1) through the 
placenta from mother to fetus if the mother 
receives primary infection during pregnancy, 
(2) consuming raw or undercooked meat if the 
meat contains tissue cysts or tachyzoite, (3) to a 
person who works in the laboratory and works 
with experimental animals infected through 
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needles and other contaminated laboratory 
equipment, (4) organ transplantation from 
donors who suffer from latent toxoplasmosis, 
and (5) a complete blood transfusion from an 
infected donor (Gandahusada, 1998; Kasper 
LH, 2001; Hiswami, 2003; Sibley et al., 2009). 
Rapid technique of early diagnosis that 
is appropriate for toxoplasmosis is needed 
because of its high prevalence rate. So far, the 
diagnosis of toxoplasmosis is detected from 
clinical symptoms, blood or a patient’s body 
tissue tests, and serological examination. 
Diagnosis of clinical symptoms is sometimes 
rather difficult because most of patients do not 
show any symptoms (asymptomatic) (Montoya 
and Liesenfeld, 2004; Robert-Gangneux et al., 
1999; Wu et al., 2009). Diagnosis by discovery 
of parasites in sufferer’s tissue or body fluids 
directly is rarely performed because of its 
difficulty in terms of taking the specimen to be 
studied. Serological tests which are currently 
most developed technique are important 
diagnostic methods for detecting T. gondii. 
Toxoplasma on the basis of antigen-toxoplasma 
will form specific antibodies in the blood serum 
of patients, but this method has a weakness that 
could not show the active phase of  T. gondii 
infection.  In addition, serological tests do not 
always show quick and accurate diagnosis 
because IgM is not found in the neonatal phase, 
or because IgM can be found for months or a 
year (Gandahusada, 1998). 
Diagnosis methods through molecular 
approaches are possibly used to improve the 
accuracy, specificity and sensitivity of early 
detection of T. gondii. DNA can be used to detect 
T. gondii by dot-blot hybridization technique. 
Diagnosis of various types of pathogens such 
as T. gondii, Plasmodium falciparum, Neisseria 
gonorrhoeae, cytomegalovirus, enterotoxigenic 
Escherichia coli using DNA probes have been 
widely used (Savva and Holliman, 1990), but 
not yet much developed in Indonesia. 
In Toxoplasmosis, a variety of target 
genes can be used for the detection of T. gondii 
and the choice of targets is very important 
because T. gondii found in three infective 
forms, which are: oosista, tachyzoite and 
cyst. (Homan et al., 2000). One of genes 
which is easy to be isolated from tachyzoite 
of T. gondii is SAG1 (Surface Antigen1) gene 
(Wu et al., 2009, Kazemi et al., 2007; Wang 
et al., 2009). SAG1 antigen is distributed 
homogeneously in the tachyzoite surface 
that makes up approximately 3-5% of total 
tachyzoite protein and is a major protein 
(Wu et al., 2009). SAG1 gene is highly 
conserved gene (Wu et al., 2009), then a 
labeled DNA probe that can detect the 
existence of complementary nucleic acids in 
field samples (clinical sample) through dot-
blot hybridization technique can be made. 
In this research, probe was labeled with 
DIGoxigenin (DIG) used PCR method to 
avoid radiation risk of a radioactive element. 
This method allows tens to hundreds of 
samples to be analyzed at the same time by 
using a membranee. Therefore, time efficiency 
can be achieved and it can be applied for 
various purposes, including clinical use in 
the laboratory, as an effective method of 
molecular diagnosis and for epidemiological 
studies to determine prevalence of cases of 
Toxoplasmosis. 
The purpose of this research was to 
create probes derived from the SAG1 gene 
sequences and to test the specificity and 
sensitivity of probe sequences of SAG1 gene 
to detect T. gondii.
Materials and Methods
T a c h i z o i t e s  P r o d u c t i o n  a n d  D N A 
Extraction 
Indonesian T. gondii isolate (IS-1) was 
maintained by intraperitoneal passage in 
Balb/C mice. IS-1 tachizoites were harvested 
from peritoneal exudate that had been 
infected 6 days earlier and purified from host 
cellular material as described by Garberi et al 
(1990). Tachizoite’s DNA were extracted using 
PureLink Genomic DNA Kit (Invitrogen).
SAG1 Gene of T. gondii amplification using 
PCR 
SAG1 gene from genomic DNA of 
T. gondii were amplified using Pure Taq 
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Ready-To-Go PCR Beads (Amersham 
Bioscience). Upstream primer F1: 5’-ATTA 
GGATCCATGTTCACTCTCAAGTGCCCT-
3 ’  and downstream pr imer  B1 :  5 ’ -
T T G A G A A T T C A G C A C A A C G G 
TGATCACTC-3’ through initial incubation 
2 min at 94 °C, followed by 30 cycles of 1 min 
at 94 °C, 1 min at 55 °C, 1 min at 72 °C, and 
final 7 min incubation at 72 °C. 
Cloning SAG1 gene in a plasmid vector
PCR product of SAG1 genes were 
cloned in pGEX-2T plasmid (Amersham 
Bioscience) according to manual instruction. 
PCR product of SAG1 gene and pGEX-
2T plamid were both cutted using BamHI 
and EcoR1 restriction enzyme in separated 
tubes prior to ligate. Transformation into 
DH5α E. coli strain were done using TSS 
method described by Chung et al (1989). TSS 
competent cells of DH5α were obtained by 10 
times-concentrating fresh exponential phase 
bacterial culture (OD600nm around 0.6) in LB 
containing 20 % PEG 6000 (w/v), 10 % DMSO 
(v/v) and 70 mM MgCl2. Different amount 
of transformation were spreaded on LB 
agar plate containing 100 μg/mL ampicilin, 
40 μL of 40 mg/mL X-Gal and 40 μL of 100 
mM IPTG and incubated overnight at 37 °C. 
Possitive transforman that contained plasmid 
with an insert will appear as white or light 
blue colonies. The succesful construction 
of transformant were named pGEX-SAG 
(pGEX-2T plasmid containing SAG1 gene). A 
mixture of pGEX-SAG positive clones were 
then cultured overnight and recombinant 
plasmids were isolated using High Pure 
Plasmid Isolation Kit (Roche). 
Designing and syntesizing of DIG labeled 
probe 
B a s i c  L o c a l  A l i g n m e n t  S e a r c h 
Tool (BLAST), an online software from 
NCBI: http://www.ncbi.nlm.nih.gov/
BLAST/, was utilized to generate probe 
TS (213 bp probe derived from SAG1 
gene). PCR  DIG Labeling mix  was used 
to label probe TS. Upstream primer (TS-
F ) :  5 ’ - A A G C A T T T C A G C C G A G T C -
3’ and downstream primer (TS-B): 5’-
GCACAACGGTAATCACTCA-3’ through 
initial incubation 3 min at 94°C, followed 
by 30 cycles of 1 min at 94°C, 30 sec at 55°C, 
25 sec at 72°C, and final 5 min incubation at 
72°C. 
Probe and dot-blot analysis 
Probe TS were diluted into 10-1 to 10-5. 1 μl 
of diluted probe were blotted into membrane 
of DIG Quantification Test Strip (Roche). 
Quantification was performed according to the 
manufacturer as briefly described: DIG Control 
Test Strip and DIG Quantification Test Strip, 
which arranged back to back, was blocked 
using blocking solution for 2 min, dipped into 
antibody binding for 5 min, blocked again with 
blocking solution for 1 min. The process was 
continued to wash the strips with washing 
buffer for 1 min, then dipped into detection 
buffer for 1 min. The strips were subsequently 
incubated in colour substrate solution for 5-
30 min. The blot signal of DIG-DNA probes 
were revealed using enzyme-catalized colour 
reaction solution (one NBT/BCIP tablet 
(Roche), in 10 ml dH20) for producing blue-
purple precipitate. 
Dot-blot hybridization of pGEX-SAG and 
hybridization detection 
pGEX-SAG was diluted into 10 ng/μl, 
1 ng/μl, 100 pg/μl, 10 pg/μl, 1 pg/μl, then 
denatured by boiling for 10 min at 100oC 
and placed into ice tube. 1 μl of diluted were 
blotted into Hybond possitive membrane 
(Roche) and dried for 2 h at 80oC in oven. 
Prehybridization for 3 to 4 h at 42°C in 
prehybridization medium (DIG easy hyb, 
Roche) then hibridyzation at 48°C overnight 
by adding 2 μl/ml probe that were labeled 
with DIG which had been denatured for 10 
min at 100°C in prehybridization medium. 
Membrane was washed two times with 
2X SSC, 0.1% SDS, for 15 min and with 
0.5X SSC, 0.1% SDS, for 15 min at 68°C 
(Roche, 2006). Hybridization detection 
with alkaline phosphatase-conjugated and 
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anti-DIGoxigenin antibody according to the 
manufacturer as briefly described: Wash 
the hybridization membrane with washing 
buffer I (100 mM maleic acid, 150 mM NaCl, 
pH 7.5, 0.3% Tween 20) for 1 - 3 min, block 
with blocking reagent (100 mM maleic acid, 
150 mM NaCl, pH 7.5, 1% blocking reagent) 
for 1 hour. The process was continued to 
wash the membrane two times with washing 
buffer I for 15 min and washing buffer II (100 
mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM 
MgCl2) for 15 min. Add BCIP/NBT substrate 
at room temperature until the best signal to 
noise ratio. Stop with excess ddH20.
Results and Discussion 
T a c h y z o i t e s  p r o d u c t i o n  a n d  D N A 
extraction 
Light microscope examination of 
extracellular parasites that were obtained from 
peritoneal exudate of infected mice showed 
that T. gondii was in tachyzoite stage, which 
can be formed as free organism or within host 
cells like leukocytes (Figure 1). DNA extract 
from tachyzoites were positively contained 
genomic DNA of T. gondii (Figure 2) and SAG1 
gene was succesfully confirmed by PCR using 
primer pairs of F1/B1 and produced amplified 
sequences with 800 bp long (Figure 3).
Cloning SAG1 gene into plasmid vector
Both cutted SAG1 gene sequence and 
pGEX-2T plasmid using BamHI and EcoRI 
were match to each others. An BamHI sticky 
end of SAG1 gene which was a peptide signal 
and coding sequence could anneal to BamHI 
cuted site of pGEX-2T. The same way, an 
EcoRI sticky end of SAG1 gene was annealed 
to the same EcoRI sticky end of the plasmid. 
These cloning method served a correct ligation 
orientation of target gene into plasmid vector. 
SAG1 gene was successfully conditioned in 
the vector pGEX-2T and transfected into E. 
coli for propagation of recombinant plasmids 
(pGEX-SAG). Confirmation was done by 
PCR and it was proved that the recombinant 
plasmid pGEX-SAG was inserted with SAG1 
gene (800 bp). 
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Probe designing from SAG1 gene of T. 
gondii 
A gene sequence that will be used as 
a template for synthesis probes must have 
high stability in an organism (Reue, 1998). 
BLAST analysis was carried out by NCBI 
website: http://www.ncbi.nlm.nih.gov/
BLAST/ Result of BLAST analysis showed 
that SAG1 gene sequence of T. gondii isolates 
IS-1 in pGEX-SAG against various strains 
of other T. gondii indicated high level of 
similarity and high stability that reached 90 
to 100%. E-value that reached 0.0 indicated 
SAG1 gene sequence of T. gondii isolates IS-
1 could be used as the basis for the design 
of probe candidate. The result of homology 
tree analysis through the Geneious program 
showed that the SAG1 gene of T. gondii 
isolates IS-1 included in the RH strain. Hartati 
(2007) had also conducted sequencing of 
SAG1 gene sequence and registered it in 
GenBank with Acc.no. AY651825. 
Probe for detection of a disease must 
have high genetic similarity with the gene of 
target organisms and low genetic similarity 
with the host genome. BLASTN analysis of 
SAG1 gene probe candidate (probe TS) on 
various nucleic acids host showed a very 
low level of similarity, same as the results of 
BLASTN analysis of TS probe candidate to 
other various parasites such as Echinococcus 
granulosis, duodenal Giardia, Plasmodium 
falciparum, Sarcocystis spp., trichinella spiralis, 
Tricomonas vaginalis, Neospora caninum, 
Isospora suis, Cryptosporidium parvum, and 
Besnoitia besnoiti. The results also showed 
that the candidate bore no resemblance 
to TS probe (0%). Therefore, the TS probe 
candidate that have been designed based on 
T. gondii has the specificity of the parasite 
T. gondii (not cross-reacted with other host 
and parasite species). Probe candidate of 
SAG1 gene sequence of T. gondii isolate IS-1, 
which has molecular weight of 213 bp, was 
proved to be conserved based on BLASTN 
analysis. 
Synthesizing and quantification of the 
probe 
Labeling of probes used recombinant 
plasmid pGEX-SAG as a template by DIG 
labeling PCR method. DIG labeled PCR 
product has a molecular weight of 213 bp. 
Qualitative analysis of the labeled probe 
results indicated that DIG labeled probe 
has a larger molecular weight than those 
which were not labeled, and DIG labeled 
PCR product showed lower band intensity 
than PCR product of non DIG labeled probe 
(Figure 4). Quantitative analysis result of DIG 
labeled DNA probes with TS probe yielded 
concentration of 56.7 pg / μl.
Dot blot hybridization of pGEX-SAG and 
hybridization detection
The result of DNA dot-blot hybridization 
with DIG labeled probes on the pGEX-SAG 
plasmid showed that the TS probe was 
capable to detect up to 100 pg/μl of T. gondii 
with TS probe concentration which was 
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added to the hybridization solution was 2 
μl/ml (Figure 5). 
In summary, SAG1 gene of T. gondii 
isolate IS-1 has a high homology through 
the strains. Probe that was derived from 
SAG1 gene could be synthesized with high 
spesificity and can be used to detect T. gondii 
from PGEX-SAG (recombinant plasmid) until 
concentration 100 pg.
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